logo

VIR

Vir Biotechnology·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

VIR fundamentals

Vir Biotechnology (VIR) released its earnings on Nov 5, 2025: revenue was 240.00K (YoY -89.92%), missed estimates; EPS was -1.17 (YoY +25.00%), missed estimates.
Revenue / YoY
240.00K
-89.92%
EPS / YoY
-1.17
+25.00%
Report date
Nov 5, 2025
VIR Earnings Call Summary for Q3,2025
  • Hepatitis Delta Milestone: ECLIPSE 1 enrollment completed 2 months early, positioning for Q1 2027 top-line data.
  • Oncology Catalyst: VIR-5500 data update in Q1 2026 to include late-line mCRPC efficacy and safety, with unique dual-masking platform.
  • Financial Strength: $810.7 million cash, runway to mid-2027, with cost-saving initiatives reducing R&D expenses 22% YoY.
  • Strategic Differentiation: Combination HDV regimen targets >60% viral suppression, vs bulevirtide's limited efficacy; Gilead's launch expected to boost disease awareness.
EPS
Revenue

Revenue & Expenses

VIR has released its 2025 Q3 earnings report, with revenue of 240.00K, reflecting a YoY change of -89.92%, and net profit of -163.14M, showing a YoY change of 23.66%. The Sankey diagram below clearly presents VIR's revenue sources and cost distribution.

Key Indicators

Vir Biotechnology (VIR) key financial stats and ratios, covering profitability, financial health, and leverage.
Vir Biotechnology (VIR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Vir Biotechnology (VIR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Vir Biotechnology (VIR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Vir Biotechnology (VIR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Vir Biotechnology (VIR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield